Moderna CEO says 'we are going to have to live with coronavirus forever'

Moderna Inc's CEO says the novel coronavirus will never disappear and will likely be around 'forever.'

During a panel discussion at the JPMorgan Healthcare Conference on Wednesday, Stéphane Bancel echoed comments from public health experts who say COVID-19 is likely going to become an endemic disease, meaning it will always present in the population but circulating at low rates.

'SARS-CoV-2 is not going away,' Bancel said, according to CNBC.' We are going to live with this virus, we think, forever.'

Additionally, he said he believes the firm's coronavirus vaccine will be effective against infection by any of the new variants from the UK, South Africa or Brazil. 

Moderna CEO Stéphane Bancel (pictured) spoke at a panel discussion at the JPMorgan Healthcare Conference on Wednesday, stating the coronavirus is not going to disappear and the general public is going to have to live with it 'forever'

Insurance Loans Mortgage Attorney Credit Lawyer

Moderna CEO Stéphane Bancel (pictured) spoke at a panel discussion at the JPMorgan Healthcare Conference on Wednesday, stating the coronavirus is not going to disappear and the general public is going to have to live with it 'forever'

Bancel added that he believes the firm's vaccine is protective against the new variants from the UK, South Africa and Brazil. Pictured: Moderna headquarters in Cambridge, Massachusetts, May 2020

Bancel added that he believes the firm's vaccine is protective against the new variants from the UK, South Africa and Brazil. Pictured: Moderna headquarters in Cambridge, Massachusetts, May 2020

Moderna's vaccine was developed in partnership with the National Institutes of Health. 

It uses part of the pathogen's genetic code called messenger RNA, or mRNA, to get the body to recognize the coronavirus and attack it if a person becomes infected.

The candidate, called mRNA-1273, works by tricking the body into producing some of the viral proteins, which the immune system then recognizes and builds a defensive response against.

When given in two doses four weeks apart, the vaccine was found to be 94.1 percent effect at preventing COVID-19 and 100 percent effective at preventing severe disease in

read more from dailymail.....

PREV Expert claims the US can stop the spread of coronavirus by JUNE
NEXT Mass trial of repurposed MS drug for Covid begins at hospital in Hull